Tag: Gary D. Glick

AzurRx BioPharma acquires US biotech company First Wave Bio for $229m

pallavi123- September 14, 2021

AzurRx BioPharma has signed a stock and cash deal worth $229 million to acquire Florida-based clinical-stage biotech company First Wave Bio. The consideration includes payments ... Read More

Novartis to acquire IFM Tre with eye on immunomodulatory drugs

pharmanewsdaily- April 14, 2019

Novartis acquisition of IFM Tre : Novartis has signed a deal worth up to $1.575 billion to acquire US biopharma company IFM Tre from IFM ... Read More